PL2007B1 - A method of producing highly active bacteria, yeasts or microbes. - Google Patents
A method of producing highly active bacteria, yeasts or microbes. Download PDFInfo
- Publication number
- PL2007B1 PL2007B1 PL2007A PL200724A PL2007B1 PL 2007 B1 PL2007 B1 PL 2007B1 PL 2007 A PL2007 A PL 2007A PL 200724 A PL200724 A PL 200724A PL 2007 B1 PL2007 B1 PL 2007B1
- Authority
- PL
- Poland
- Prior art keywords
- bacteria
- microbes
- yeasts
- vaccines
- cultures
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title claims description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 5
- 229960005486 vaccine Drugs 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims 2
- 230000001665 lethal effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 2
- 206010061393 typhus Diseases 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
Description
Wykryto, ze wlasnosc bakteryj, droz¬ dzy lub mikrobów niszczenia innych bak¬ teryj mozna tak silnie rozwinac i wyko¬ rzystac, przenoszac ich hodowle na inne kultury bakteryj, ze w ten sposób mozna otrzymywac nowe rodzaje lekarstw i szcze¬ pionek, znacznie przewyzszajace srodki stosowane w tym celu i znajdujace sie o- becnie w handlu.To wspólne rozwijanie sie bakteryj, po¬ siadajacych wlasnosc tepienia innych bak¬ teryj i trawienia bialka, albo bakteryj, prze¬ ciwdzialajacych fermentacji, z bakterjami zwalczanemi lub przesiedlanie hodowli pierwszych na podobne kultury zwalczane powieksza tak dalece wlasnosc niszczyciel¬ ska bakteryj i t. p., iz te ostatnie nabie¬ raja zdolnosci niszczenia zwalczanego cia¬ la w tak krótkim przeciagu czasu, ze sa¬ me nie zdazaja w okresie tym wywrzec dzialania szkodliwego.Jesli np. rozwijac i hodowac na kultu¬ rach tyfusowych np. Kazzilus subtilis, al¬ bo mesentericus, albo mycoides i prze¬ siedlac je systematycznie, co pewien! o- kres czasu, kilkakrotnie na nowe kultury tyfusowe, to otrzymujemy, po przeróbce sposobami zwyklem! lub znanemi, szcze¬ pionki, o dzialaniu znacznie przewyzsza- jacem znajdujace sie w handlu srodki, sto¬ sowane obecnie do celów profilaktyki i im- munizacji. To samo zachodzi np,, skoro bakterje, posiadajace wlasnosci niszcze¬ nia innych bakteryj, hodowac na gronkow-cach lub na bacylach tuberkulicznych i, przez systematyczne przenoszenie na in¬ ne kultury tuberkulicznej, skierow&c ich dzialanie przeciw tym tylko ostatnim. W ten sposób mozna wogóle otrzymywac le¬ karstwa i szczepionki o stopniu dzialania znacznie wyzszym od znanych obecnie.Szczepionki te i lekarstwa wykazuja ponadto te wyzszosc, iz mozna je jaknajdo- kladniej wypróbowac na zwierzetach, po^ dobnie, jak to czynimy £ surowicami sto- sowanemi w chorobach zakaznych.Sposób powyzszy mozna ponadto sto¬ sowac i do innych, niekoniecznie farma¬ ceutycznych celów, np. dla wytwarzania odpowiednich w sensie technicznym droz* dzy, co oznacza znaczny postep w sposo¬ bach pracy. PLIt has been found that the property of bacteria, yeast or microbes to destroy other bacteria can be so strongly developed and exploited by transferring their cultures to other cultures of bacteria that new types of drugs and vaccines can be obtained in this way, far exceeding the resources used for this purpose and presently commercially available. This is the joint development of bacteria that have the property of suppressing other bacteria and digesting protein, or bacteria that prevent fermentation, with the bacteria that are to be combated, or the resettlement of primary cultures to similar cultures the target increases the destructive properties of bacteria and so on that the latter acquire the ability to destroy the target body in such a short period of time that they themselves do not have a chance of causing a harmful effect during this period. typhus cultures, for example, Kazzilus subtilis, or mesentericus, or mycoides, and relocate them systematically, to be sure! the period of time, several times for new typhus cultures, we get it, after processing in the usual ways! or a known vaccine with an effect far exceeding that of the commercial agents currently used for prophylaxis and immunization. The same is true, for example, if bacteria having the property of destroying other bacteria are grown on staphylococci or tubercular bacilli and, by systematic transfer to other tubercular cultures, direct their action against only the latter. In this way it is possible to obtain medications and vaccines with a degree of action much higher than those known today. Moreover, these vaccines and drugs show the superiority that they can be tested in animals as well as we do with sera. The above method can also be used for other, not necessarily pharmaceutical, purposes, for example for the production of technically suitable yeast, which means a significant progress in working methods. PL
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2007B1 true PL2007B1 (en) | 1925-05-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| D’Alterio et al. | Postal survey of the population of South American camelids in the United Kingdom in 2000/01 | |
| Blair | Immunology of the mouse mammary tumour virus (MTV): a qualitative in vitro assay for MTV | |
| PL2007B1 (en) | A method of producing highly active bacteria, yeasts or microbes. | |
| Hudson | Aspergillus fumigatus infection in the eyes of baby chicks | |
| KEENEY et al. | Human infection with the Newcastle virus of fowls | |
| Biglake | Preliminary communication on the cultivation of Besnoitia besnoiti (Morotel, 1912) in tissue culture and embryonated eggs | |
| MacFarlane et al. | Cultivation of toxoplasma in the developing chick embryo. | |
| El-Yuguda et al. | Field trial of a thermostable peste des petits ruminants (PPR) vaccine in a semi-arid zone of Nigeria | |
| Hudson et al. | Physiological disturbance of the reproductive system in white leghorn cockerels following the feeding of enheptin | |
| Ganguly et al. | Dermatophytosis in animals: an overview | |
| Fastier | The effect of physical agents on hydatid scolex viability | |
| Kligler et al. | Transmission of fowl-pox by mosquitoes: further observations | |
| Hopkins | Thermal stability of infectious bronchitis virus in the presence of salt solutions | |
| Magill et al. | Antigenically different strains of virus from a localized influenza outbreak | |
| Wakerlin | The influence of the size of the inoculum on the incubation period and course of rabbit syphilis | |
| Miller et al. | Protection of mice against lethal action of gonococcal endotoxin by penicillin. | |
| Carr | Prolonged antibody production following recovery of fowls from Rous No. 1 sarcoma | |
| Stone | Experimental Formation of Accessory Organs in Mid Body Lateral-Line of Amphibians. | |
| Hindle et al. | The electrical charge of yellow-fever virus | |
| GB1133958A (en) | Process for the manufacture of a distemper vaccine | |
| Findlay | Pleuropneumonia-like organisms and arthritis | |
| Rulon | The alteration of developmental pattern in the sand dollar by pilocarpine | |
| RU2220742C2 (en) | Combined vaccine against anthrax in animals | |
| Sprunt et al. | In vivo neutralization of pertussis toxin with pertussis antitoxin | |
| Goodpasture et al. | The Protective Action of Rabbit Serum for Vaccinia Virus at High Temperatures |